MedPath

Management of kidney stones by giving decoction orally.

Not Applicable
Conditions
Health Condition 1: N202- Calculus of kidney with calculus of ureter
Registration Number
CTRI/2022/02/040023
Lead Sponsor
Mali Shubham Sunil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients fulfilling the diagnostic criteria which are based on signs and

symptoms of Urolithiasis will be selected

for study.

Patients with size of calculus less than < 10 mm.

Patients having calculus at Kidney, Ureter, Bladder.

Patients willing to participate in clinical trial with written consent.

Exclusion Criteria

Pregnancy / Lactation

Patients not willing to participate in trial.

Patients suffering from associated Urolithiasis with following disease will be excluded.

Immunocompromised patient.

Diabetic patients.

Renal failure, congenital disorders like ectopic kidney, horse shoe kidney,

stricture at Uretero Vesical & Uretero Pelvic junction, neoplasm.

Patients having severe hydronephrosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in size of urinary calculi with treatment.Timepoint: Up to 30 days.
Secondary Outcome Measures
NameTimeMethod
Signs and symptoms of Urolithiasis will improve with treatment.Timepoint: Up to 30 days.
© Copyright 2025. All Rights Reserved by MedPath